KDM4B and breast carcinoma: Yang et al. [151] showed that JmjD2B is highly expressed in ER-positive primary breast cancer and that JmjD2B is a target gene for ER itself, underlining the evidence for the importance of JmjD2B in the etiology of ER-positive breast cancers [152,153].